Advanced search×

Effects of short-chain fructooligosaccharides on satiety responses in healthy men and women

Appetite 56(1):7 (2011) PMID 21146572

In view of a dramatic increase in the incidence of obesity, the present study examined the appetite effects of a functional fiber as a potential dietary intervention. Fiber may increase satiety. Satiety effects also may be linked to colonic fermentation. Short-chain fructooligosaccharide (scFOS) are fermentable fibers that can be added to foods to influence these actions. The primary objective of this study was to determine if scFOS affects satiety and hunger and has an additive effect on food intake. Using a double-blind crossover design, 20 healthy subjects were assigned to consume two separate doses of 0g, 5g, or 8g of scFOS. The first dose was mixed into a hot cocoa beverage and served with a breakfast meal of a bagel and cream cheese. A beverage was used in the test meal due to the ease with which scFOS can be added to this medium. Satiety was assessed with visual analogue scales (VASs) at 0, 15, 30, 45, 60, 90, 120, 180, and 240min. Ad libitum food intake was measured at a lunch meal provided at the test site at 240min. Subjects then recorded their food intake over the remainder of the 24-h study day. The second dose of scFOS was consumed in the form of 3 solid, chocolate-flavored chews (51-67 total kcal) without additional food or drink, 2h prior to the subject's dinner meal. Breath hydrogen measures were collected prior to the breakfast test meal (0min) and the ad libitum lunch (240min). Gastrointestinal tolerance was evaluated over the course of the 24-h study day using VAS. All treatments were well tolerated. No differences in subjective satiety over the morning, or food intake at lunch, were found. Over the remainder of the day, the high dose of scFOS reduced food intake in women, but increased food intake in men, suggesting a gender difference in the longer-term response. Breath hydrogen, used as a marker of fermentation, increased in a dose-dependent manner. These results indicate that scFOS undergoes fermentation within 240min; however, acceptable amounts of scFOS did not enhance acute satiety or hunger.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.appet.2010.12.005
Version: za2963e q8za0 q8zb9 q8zcf q8zd5 q8zec q8zfa q8zg4

Similar articles you may find interesting…

  1. Clinical immunogenicity specificity assessments: A platform evaluation

    J Pharm Biomed Anal 54(3):7 (2011) PMID 21035975

    We believe that this challenge will be relevant to others in the field. In this paper, we will describe our challenges with one of these antibodies, monoclonal antibody therapeutic X (rhuMAb X). This paper presents extensive evaluation of two technology platforms and various conditions to evaluate a...
  2. Preclinical development of new drugs that enhance thyroid hormone metabolism and clearance: inadequacy of using rats as an animal model for ...

    Am J Ther 13(2):141-4 (2006) PMID 16645431

    New drugs that enhance metabolism or clearance of thyroid hormones in rats often trigger a sequence of toxicity events during chronic administration: reduction of thyroxine, elevation of thyroid-stimulating hormone (TSH) levels, and thyroid gland hyperfunction/growth. Hepatocellular hypertrophy and...
  3. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells.

    Audio, Transactions of the IRE Professi... 333(2):593-601 (2010) PMID 20103585

    We examined the effects of SRT1720 on mitochondrial biogenesis and function in primary cultures of renal proximal tubule cells (RPTC). We also tested the ability of this compound to restore mitochondrial functions following oxidant-induced RPTC injury. SRT1720 (3-10 muM) induced mitochondrial biogen...